Clinical Trials Logo

Dwarfism clinical trials

View clinical trials related to Dwarfism.

Filter by:

NCT ID: NCT03131349 Completed - Clinical trials for Zinc; Deficiency With Anemia

Zinc and Iron in Children With Short Stature

zincandiron
Start date: June 1, 2017
Phase:
Study type: Observational [Patient Registry]

Short stature is defined as height below 3rd centile or less than two standard deviations below the median height for that age and sex according to the population standard zinc and iron have important role in growth for children

NCT ID: NCT03015909 Completed - Clinical trials for Chronic Renal Failure

Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

Start date: August 11, 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the ease of use, preference, and safety after 8 weeks subcutaneous administration of EutropinPen Inj. in patients pretreated with recombinant human growth hormone by reusable device.

NCT ID: NCT02879747 Completed - Short Stature Clinical Trials

Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children

MAINTENANCE
Start date: December 2003
Phase: Phase 2/Phase 3
Study type: Interventional

The objective was to study whether normal growth velocity can be maintained with adapted GH dosage in GH treated prepubertal children who have responded to GH treatment with fulfilled catch up growth (=difference to target height reached, less than - 0.6 SDS).

NCT ID: NCT02826902 Completed - Osteoarthritis Clinical Trials

Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial

Start date: September 27, 2016
Phase: N/A
Study type: Interventional

The effect of total intravenous anesthesia (TIVA) versus inhalational anesthesia on the quality of recovery from surgery has been reported in several different types of operations. The Quality of Recovery 40 (QoR-40) questionnaire is designed multi-dimensionally to assess the degree of recovery after anesthesia and surgery, and has been validated in previous studies. The present study aims to compare the quality of recovery with the QoR-40 questionnaire, in patients undergoing correctional tibial osteotomy under general anesthesia with either TIVA with propofol or inhalational anesthesia with desflurane.

NCT ID: NCT02636270 Completed - Short Stature Clinical Trials

IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency

Start date: December 21, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

With this study we want to investigate the pharmacokinetic (PK) effect of a single injection of rhIGF-1 in patients with PAPP-A2 mutations compared to heterozygous carriers and healthy controls. This will be followed by treatment of PAPP-A2 deficient patients with IGF-1 for a period of one-year to assess growth velocity. Additionally, we want to further describe the phenotypic characteristics of patients with PAPP-A2 deficiency.

NCT ID: NCT02412943 Completed - Clinical trials for Short Stature, Idiopathic

Pappalysin 2 (PAPP-A2) Enzyme Replacement

Start date: April 2015
Phase: Phase 1
Study type: Interventional

This study evaluates the transfusion of fresh frozen plasma containing the enzyme PAPP-A2 into the a female adult. This female adult has a mutated version of PAPP-A2 that prevents the unbinding of IGF-1 from IGF binding proteins. The investigator's hypothesize that transfusion of plasma with donor PAPP-A2 will lead to the unbinding of IGF-1 from its binding proteins and that they will be able to measure free IGF-1 in the blood of this female adult.

NCT ID: NCT02389803 Completed - Short Stature Clinical Trials

Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys

Start date: June 2015
Phase: N/A
Study type: Interventional

Study design: Double blind, randomized, placebo controlled study. Participants will be randomly assigned either to the intervention group or the placebo control group. Randomization for the two study groups will be made in a ratio of 1:1. The primary objective of the study is to assess the effect of 6-12 months treatment with nutritional supplementation standardized formula, in short and lean boys adolescents on weight Standard Deviation Score (SDS) and height SDS The Secondary Objectives of the study are to assess the effect of 6-12 months treatment with nutritional supplementation standardized formula, in short and lean boys adolescents on BMI SDS, growth velocity, time to puberty, quality of life and self-esteem The study will continue for 6 months of intervention versus active placebo, with additional optional 6 months (an extension period), in which participants at both groups, the intervention and the placebo, will be offered to continue their participation in the study with the study supplement. All analyses of the effect's on primary and secondary outcome measurements will take into account the consumption rate of the study formula/placebo

NCT ID: NCT02137538 Completed - Short Stature Clinical Trials

Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole

Start date: November 18, 2009
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine if there are differences in the final height or hormone profile of short pubertal boys placed on different forms of aromatase inhibitor now routinely used to increase stature: Anastrozole and Letrozole. It also should determine if there are differences in the side effect profiles of the two drugs to be used.

NCT ID: NCT01927861 Completed - Genetic Disorder Clinical Trials

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome

Start date: August 19, 2013
Phase: Phase 3
Study type: Interventional

This trial is conducted in Asia. The aim of the trial is to investigate the long-term efficacy and safety of two doses of NN-220 (somatropin) in short stature due to Noonan syndrome.

NCT ID: NCT01911260 Completed - Short Stature Clinical Trials

Weekly Zinc Chelate Supplementation on Children's Growth

APZinc
Start date: September 2000
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to measure the effect of weekly zinc supplementation on schoolchildren with growth deficit or normal stature.